๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The pharmacokinetics of the enantiomers of atenolol

โœ Scribed by Boyd, Rebecca A; Chin, Shu K; Don-Pedro, Oluta; Williams, Roger L; Giacomini, Kathleen M

Book ID
109844658
Publisher
Nature Publishing Group
Year
1989
Tongue
English
Weight
666 KB
Volume
45
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of reboxetine enantiome
Pharmacokinetics of reboxetine enantiomers in the dog
โœ E. Frigerio; A. Benecchi; G. Brianceschi; C. Pellizzoni; I. Poggesi; M. Strolin ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 2 views

Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive

Pharmacokinetic studies with atenolol in
Pharmacokinetic studies with atenolol in the dog
โœ Dr. James McAinsh; Brian F. Holmes ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 445 KB ๐Ÿ‘ 2 views

The pharmacokinetics of the cardioselective ,!hadrenoreceptor blocking agent atenolol have been determined following intravenous and oral dosing t o the dog. After intravenous administration at 200mg the blood levels of parent drug were found to decay tri-exponentially with a final elimination phase